FDA.reportPublic FDA data

50 ML ramucirumab 10 MG/ML Injection [Cyramza]

RxCUI
1657781
RxNorm name
50 ML ramucirumab 10 MG/ML Injection [Cyramza]
Display name
50 ML ramucirumab 10 MG/ML Injection [Cyramza]
Full name
50 ML ramucirumab 10 MG/ML Injection [Cyramza]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125477Cyramzaramucirumab351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
c6080942-dee6-423e-b688-1272c2ae90d450 ML ramucirumab 10 MG/ML Injection [Cyramza]SBD47These highlights do not include all the information needed to use CYRAMZA safely and effectively. See full prescribing information for CYRAMZA. CYRAMZA (ramucirumab) injection, for intravenous use Initial U.S. Approval: 201420251218
c6080942-dee6-423e-b688-1272c2ae90d4Cyramza 500 MG per 50 ML InjectionSY47These highlights do not include all the information needed to use CYRAMZA safely and effectively. See full prescribing information for CYRAMZA. CYRAMZA (ramucirumab) injection, for intravenous use Initial U.S. Approval: 201420251218
c6080942-dee6-423e-b688-1272c2ae90d4Cyramza 500 MG in 50 ML InjectionPSN47These highlights do not include all the information needed to use CYRAMZA safely and effectively. See full prescribing information for CYRAMZA. CYRAMZA (ramucirumab) injection, for intravenous use Initial U.S. Approval: 201420251218